x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAB-0012245
| Product Information | |
|---|---|
| Clonality | Polyclonal |
| Host Species | Rabbit |
| Reactivity | Human |
| Applications | WB, IP |
| Product Description | Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human Lysyl Hydroxylase 2 protein. Antibodies are purified by peptide affinity chromatography. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | PLOD2 |
| UniProt No. | O00469 |
| Gene ID | 5352 |
| Gene Description | The Extracellular Matrix is a complex network of macromolecules that provides structural tissue support to cells in the basement membrane and interstitial matrix. It is composed of many molecules, including proteins, glycoproteins, proteoglycans, and polysaccharides. One of the major proteins that comprises the ECM, and the human body, is collagen. Collagens are a large family of proteins. They are trimeric molecules comprised of three alpha polypeptide chains that form a triple-helix structure that is characteristic of all collagens. The large family of collagens is divided into three subgroups: fibrillar collagens, non-fibril forming collagens, and fibril-associated collagens. These subgroups differ in their structure and supramolecular assembly.Collagen content and abundance determines the nature of the scaffold of the ECM, and is known to influence pathological events such as tumor growth and invasion, and also tissue fibrosis. Lysyl Hydroxylase 2, is an important enzyme that mediates the hydroxylation of lysines in collagen-like peptides in the ER, a key step that contributes to cross-linking of collagen fibrils. Interestingly, overexpression of Lysyl Hydroxylase 2 observed in multiple cancers, driven potentially through hypoxia-induced mechanisms, is related to a poor prognosis, tumor migration, invasion, and EMT. Current interest exists in pharmaceutical inhibition of this enzyme for therapeutic intervention to prevent metastasis and tumor spread. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
| Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
